Last reviewed · How we verify
NCT05311241: TELET
Teleconsultation in Ambulatory Care in France
trial in Telehealth in 84,000 participants. Completed in 21 March 2022.
21 March 2022
Quick facts
| Lead sponsor | Les Entreprises de Télémédecine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 84,000 |
| Start date | 1 February 2022 |
| Primary completion | 21 March 2022 |
| Estimated completion | 21 March 2022 |
| Sites | 1 location across France |
Conditions studied
- Telehealth — all drugs for Telehealth →
- Telemedicine — all drugs for Telemedicine →
- Teleconsultation — all drugs for Teleconsultation →
Sponsor
Les Entreprises de Télémédecine
Who can join
Eligibility, any sex, with Telehealth or Telemedicine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Teleconsultation is a telemedicine medical act carried out remotely via information and communication technologies. This medical procedure has been legal in France since 2010 and reimbursed by the National Health Insurance under certain conditions since 2018. In 2020, following the COVID-19 epidemic, the lockdowns and the extension of the scope of financial coverage, 17 million teleconsultations have been reimbursed. To date, few scientific studies have been published in France to precisely describe the use of the service giving access to outpatient teleconsultation, in particular since the major increase in activity linked to the COVID-19 epidemic. The objective is to describe the use of the service giving access to outpatient teleconsultation carried out in France by teleconsultation companies and compare the use of the teleconsultation service according to the medical density of the territory.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluating the Impact of Teleconsultations on Access to Ambulatory Primary Care in Medically Underserved Areas: A National Observational Cross-Sectional Multicenter Study.
Ohannessian R, Yaghobian S, Simon R, Poinsot-Chaize G, et al · · 2024 · cited 7× · PMID 37643308 · DOI 10.1089/tmj.2023.0274
Verify or expand the search:
- PubMed search for NCT05311241
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Telehealth
Currently open trials in the same condition.
- NCT07034287 — Modifying the Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department for · NA · recruiting
- NCT06971146 — Nurse-Led Telehealth for Gout · NA · recruiting
- NCT06992778 — Effectiveness and Acceptability of Remote Fine-Tuning of Hearing Aids in Danish Adults · NA · recruiting
- NCT07427693 — Usability, Acceptability and Effect of a Mobile Application and Connected Object for Older Women With UI · NA · active not recruiting
- NCT06775288 — Hypoglycemia Prevention and Awareness Program · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05311241 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Les Entreprises de Télémédecine
- Last refreshed: 5 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05311241.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing